GPR41 and GPR43 in Obesity and Inflammation - Protective or Causative?
about
Human and mouse monocytes display distinct signalling and cytokine profiles upon stimulation with FFAR2/FFAR3 short-chain fatty acid receptor agonistsA Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique Gi-functional BiasShort Chain Fatty Acids Prevent High-fat-diet-induced Obesity in Mice by Regulating G Protein-coupled Receptors and Gut Microbiota.Impact of the microbial derived short chain fatty acid propionate on host susceptibility to bacterial and fungal infections in vivo.Key Questions for Translation of FFA Receptors: From Pharmacology to Medicines.Free Fatty Acid Receptors and Cancer: From Nutrition to Pharmacology.Short chain fatty acids ameliorate immune-mediated uveitis partially by altering migration of lymphocytes from the intestine.Fiber-Mediated Nourishment of Gut Microbiota Protects against Diet-Induced Obesity by Restoring IL-22-Mediated Colonic Health.Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury.Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors.Influence of Altered Gut Microbiota Composition on Aging and Aging-Related Diseases.The Anti-inflammatory Effects of Short Chain Fatty Acids on Lipopolysaccharide- or Tumor Necrosis Factor α-Stimulated Endothelial Cells via Activation of GPR41/43 and Inhibition of HDACs.
P2860
Q28278805-FAA21249-6964-4825-A4E7-A95CD364CDC5Q37227642-2CAE7220-08A4-4A52-B4C1-26D1C82B5B24Q37444024-883DC05A-EB05-4E9A-A316-D4CB05D141F3Q37448992-8FD95933-8605-4043-AE67-3DBF90FF3BCFQ39016250-7E61EBE5-3857-4298-8E87-439067CA0A61Q39273221-38D35807-694F-4426-8197-7469F69C07D3Q41718001-17475012-1FE1-42EE-A65E-29E1B59AF40FQ49587798-BA8537A8-6C2C-4219-AF29-FCF5B17B0821Q51191034-AB6BB498-10FE-4D35-996F-1E7F3EFDE461Q51417749-0A874274-59E2-4C34-80F3-091838D6BE31Q51759202-312660C6-39A7-413E-8C24-A60EFE831D8EQ55347800-315BFF79-8847-4D9B-8363-29CCBB71C766
P2860
GPR41 and GPR43 in Obesity and Inflammation - Protective or Causative?
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
GPR41 and GPR43 in Obesity and Inflammation - Protective or Causative?
@ast
GPR41 and GPR43 in Obesity and Inflammation - Protective or Causative?
@en
GPR41 and GPR43 in Obesity and Inflammation - Protective or Causative?
@nl
type
label
GPR41 and GPR43 in Obesity and Inflammation - Protective or Causative?
@ast
GPR41 and GPR43 in Obesity and Inflammation - Protective or Causative?
@en
GPR41 and GPR43 in Obesity and Inflammation - Protective or Causative?
@nl
prefLabel
GPR41 and GPR43 in Obesity and Inflammation - Protective or Causative?
@ast
GPR41 and GPR43 in Obesity and Inflammation - Protective or Causative?
@en
GPR41 and GPR43 in Obesity and Inflammation - Protective or Causative?
@nl
P2860
P3181
P356
P1476
GPR41 and GPR43 in Obesity and Inflammation - Protective or Causative?
@en
P2093
Jeak Ling Ding
P2860
P3181
P356
10.3389/FIMMU.2016.00028
P407
P50
P577
2016-01-01T00:00:00Z